Scaling Phathom Pharmaceuticals: An Interview with Martin Gilligan, Chief Commercial Officer

For nearly the past four years, Martin Gilligan has served as the Chief Commercial Officer at Phathom Pharmaceuticals. Phathom, a relatively new player in the gastrointestinal (GI) space, is a commercial-stage biopharmaceutical company developing new treatments for GI diseases. Gilligan has three decades of experience under his belt to help lead Phathom’s sales and market … Read full-story